Calithera Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Calithera Biosciences

15/11/2022 03:58

* Calithera Biosciences Inc  CALA.OQ  reported a quarterly
adjusted loss of $2.01​​ per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for a loss of $1.93 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Calithera Biosciences Inc's reported EPS for the quarter
was a
loss of $2.01​.
    * The mean earnings estimate of analysts had risen by
about 28.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Calithera Biosciences Inc shares had fallen by 11.2% this
quarter and lost 80.4% so far this year.
    * The company reported a quarterly loss of $9.8 million.
    * Wall Street's median 12-month price target for Calithera
Biosciences Inc is $17.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
15 at 03:58 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -1.93          -2.01          Missed
 Jun. 30 2022      -2.65          -1.59          Beat
 Mar. 31 2022      -3.70          -3.60          Beat
 Dec. 31 2021      -4.80          -4.80          Met